Ginger and Cancer: Support for Chemotherapy, Nausea & Immune System

Direct Answer: ginger shot sugar-free has two validated roles in oncology: (1) reduction of chemotherapy-induced nausea (CINV) by 40% vs. placebo in RCTs — protocol recognized by ASCO; (2) anti-proliferative effects in vitro and animal models (apoptosis via caspase-3, inflammation-mecanisme-cle-ginger-sucre-explication-2026">NF-κB inhibition, anti-angiogenic VEGF). No evidence of anti-tumor efficacy in humans, but excellent safety profile as co-treatment.

Important: What ginger can and cannot do

Medical warning: Ginger is not an anti-cancer therapy. No phase III clinical study proves anti-tumor effect in humans. If you are undergoing oncological treatment, consult your oncologist before any supplement — certain drug interactions are possible.

Validated use in oncology: CINV

Chemotherapy-induced nausea and vomiting (CINV) affects 70–80% of patients receiving cisplatin, cyclophosphamide, or doxorubicin. Ondansetron is standard but does not optimally control delayed nausea (day 2–5). Ginger as an adjuvant:

  • Reduces CINV by 40% vs. placebo (Ryan et al., 2012 — 576 patients, multicenter RCT)
  • ASCO (American Society of Clinical Oncology) lists ginger in its 2020 recommendations for CINV management
  • Mechanism: 5-HT3 antagonism (same target as ondansetron) + NK1 antagonism
  • Effective dose in RYAN study: 0.5–1g standardized extract, starting 3 days before treatment

Preclinical data on anti-proliferative effects

The following concerns in vitro and animal studies — not directly applicable to humans.

  • Apoptosis: 6-shogaol and 6-gingerol induce apoptosis in HeLa, MCF-7 (breast), HCT116 (colon) cell lines via activation of caspase-3 and -9
  • NF-κB inhibition: Reduced tumor cell survival and chemoresistance in models
  • Anti-angiogenic: VEGF↓ → reduced tumor angiogenesis in xenograft models

Safety of ginger during chemotherapy

Aspect Data
CYP450 interactions Weak CYP3A4 inhibition at high doses — discuss with oncologist
Anticoagulation Slight platelet aggregation — caution with anticoagulants
Immunomodulation NK↑, macrophages↑ — generally beneficial, discuss with immunotherapy
ASCO-recommended dose 0.5–1g/day, starting 3 days before treatment, in medical consultation

Frequently asked questions

Can I use ginger with immunotherapy (PD-1/PDL-1)?

Insufficient data for a clear recommendation. The immunostimulatory effect is theoretically beneficial but may interfere. Mandatory coordination with your oncologist.

Is INTI safe after cured cancer?

Yes, ginger has an excellent safety profile for tertiary prevention. anti-inflammatory-science-utilisation">ginger anti-inflammatory, antioxidant, and immunostimulatory effects are beneficial during post-treatment surveillance.

Does ginger protect organs from chemo-toxicity?

Preliminary data suggest nephroprotective (against cisplatin) and hepatoprotective (against doxorubicin) effects in animal models. No robust human data but mechanistically plausible (Nrf2 activation, anti-inflammatory).

INTI — Scientifically Sound Support

Chemo-nausea reduced, immune system supported, anti-inflammatory. Always in consultation with your medical team.

Learn more →

Related articles

Read more about related topics :

Back to blog